Company Data
Prime Medicine Inc.
Ticker
PRME
Current Price
$3.71 -12.29%
Market Cap
$670.1M
Price Target
Refer to Report
Volume
2.1M
52wk Range
$2.67 - $6.94
Overview
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs.